Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiolabeled ACT-246475 mass balance and pharmacokinetics study in healthy male volunteers
NL-OMON46067Active, not recruiting
- Sponsor
- Idorsia
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of selatogrel in myocardial infarction (MI), sponsored by Idorsia. Primary endpoints: Rate and routes of elimination and mass balance, Pharmacokinetics of total 14C-radioactivity in whole blood and plasma and 3 more. Started Jul 2018; status: active, not recruiting.
02
Drugs
selatogrel
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON46067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46067.